# Novo Nordisk net income entity: /record/novo-nordisk.md predicate: net_income page: /record/novo-nordisk/net_income as_of: 2026-11-10 cite: AsOf. "Novo Nordisk net income: 102,434,000,000 DKK", as of 2025-12-31. Claim clm_F536BDE429B7, https://asof.is/claim/clm_F536BDE429B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm. As of November 10, 2026, Novo Nordisk's net income on the AsOf record is 102.43 billion DKK, dated December 31, 2025, from a primary source (sec.gov). 7 claims on Novo Nordisk's net income, 1 open and 6 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Current net income What the record asserts on 2026-11-10. - [Novo Nordisk](/record/novo-nordisk.md) | net_income | 102,434,000,000 DKK | valid 2025-12-31 to present | conf 0.95 | valid | [clm_F536BDE429B7](/claim/clm_F536BDE429B7.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Novo Nordisk](/record/novo-nordisk.md) | net_income | 38,951,000,000 DKK | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_2112055E65B9](/claim/clm_2112055E65B9.md) | [clm_DA4855A5F51A](/claim/clm_DA4855A5F51A.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | net_income | 42,138,000,000 DKK | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_8F5ADB2C07ED](/claim/clm_8F5ADB2C07ED.md) | [clm_2112055E65B9](/claim/clm_2112055E65B9.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | net_income | 47,757,000,000 DKK | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_1A208DF6F487](/claim/clm_1A208DF6F487.md) | [clm_8F5ADB2C07ED](/claim/clm_8F5ADB2C07ED.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | net_income | 55,525,000,000 DKK | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_A49F4F076521](/claim/clm_A49F4F076521.md) | [clm_1A208DF6F487](/claim/clm_1A208DF6F487.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828023001868/0001628280-23-001868-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | net_income | 83,683,000,000 DKK | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_8A5C5EE097FD](/claim/clm_8A5C5EE097FD.md) | [clm_A49F4F076521](/claim/clm_A49F4F076521.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/0001628280-24-002635-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | net_income | 100,988,000,000 DKK | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_F536BDE429B7](/claim/clm_F536BDE429B7.md) | [clm_8A5C5EE097FD](/claim/clm_8A5C5EE097FD.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm - [Novo Nordisk](/record/novo-nordisk.md) | net_income | 102,434,000,000 DKK | valid 2025-12-31 to present | conf 0.95 | valid | [clm_F536BDE429B7](/claim/clm_F536BDE429B7.md) sources: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm ## What replaced what - 38.95 billion DKK (2019-12-31 to 2020-12-31, [clm_DA4855A5F51A](/claim/clm_DA4855A5F51A.md)) was replaced by 42.14 billion DKK from 2020-12-31 ([clm_2112055E65B9](/claim/clm_2112055E65B9.md)) - 42.14 billion DKK (2020-12-31 to 2021-12-31, [clm_2112055E65B9](/claim/clm_2112055E65B9.md)) was replaced by 47.76 billion DKK from 2021-12-31 ([clm_8F5ADB2C07ED](/claim/clm_8F5ADB2C07ED.md)) - 47.76 billion DKK (2021-12-31 to 2022-12-31, [clm_8F5ADB2C07ED](/claim/clm_8F5ADB2C07ED.md)) was replaced by 55.53 billion DKK from 2022-12-31 ([clm_1A208DF6F487](/claim/clm_1A208DF6F487.md)) - 55.53 billion DKK (2022-12-31 to 2023-12-31, [clm_1A208DF6F487](/claim/clm_1A208DF6F487.md)) was replaced by 83.68 billion DKK from 2023-12-31 ([clm_A49F4F076521](/claim/clm_A49F4F076521.md)) - 83.68 billion DKK (2023-12-31 to 2024-12-31, [clm_A49F4F076521](/claim/clm_A49F4F076521.md)) was replaced by 100.99 billion DKK from 2024-12-31 ([clm_8A5C5EE097FD](/claim/clm_8A5C5EE097FD.md)) - 100.99 billion DKK (2024-12-31 to 2025-12-31, [clm_8A5C5EE097FD](/claim/clm_8A5C5EE097FD.md)) was replaced by 102.43 billion DKK from 2025-12-31 ([clm_F536BDE429B7](/claim/clm_F536BDE429B7.md)) ## Questions this record answers ### What is Novo Nordisk's current net income? 102.43 billion DKK, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 10, 2026 (status valid, confidence 0.95). ### When did Novo Nordisk's net income last change? The latest value on the record is 102.43 billion DKK, dated December 31, 2025; before it the record holds 100.99 billion DKK, dated December 31, 2024 and closed on December 31, 2025. ### What was Novo Nordisk's net income before 102.43 billion DKK? 100.99 billion DKK, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/novo-nordisk/net_income (markdown: /record/novo-nordisk/net_income.md) - Entity twin: /record/novo-nordisk.md ยท timeline: /timelines/novo-nordisk.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.